Clinical Trial Update: Satisfaction/Quality of Life With Rivaroxaban in DVT (Deep Venous Thrombosis) Indication

View source ↗

Summary

This completed clinical trial update from Bayer evaluates satisfaction and quality of life in patients with deep vein thrombosis treated with rivaroxaban (NCT01…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis

Drugs mentioned

• Xarelto (rivaroxaban)

Snippet

Sponsor: Bayer | Conditions: Venous Thrombosis | Status: COMPLETED